Marc Benioff - Jan 19, 2022 Form 4 Insider Report for SALESFORCE.COM, INC. (CRM)

Signature
/s/ Anisha Mehta, Attorney-in-Fact for Marc Benioff
Stock symbol
CRM
Transactions as of
Jan 19, 2022
Transactions value $
-$340,504
Form type
4
Date filed
1/20/2022, 08:11 PM
Previous filing
Jan 19, 2022
Next filing
Jan 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $186K +2.3K +0.01% $80.99 28.9M Jan 19, 2022 Direct F1, F2
transaction CRM Common Stock Sale -$56.4K -249 0% $226.67 28.9M Jan 19, 2022 Direct F1, F2, F3
transaction CRM Common Stock Sale -$143K -628 0% $227.91 28.9M Jan 19, 2022 Direct F1, F2, F4
transaction CRM Common Stock Sale -$126K -550 0% $228.90 28.9M Jan 19, 2022 Direct F1, F2, F5
transaction CRM Common Stock Sale -$125K -544 0% $230.26 28.9M Jan 19, 2022 Direct F1, F2, F6
transaction CRM Common Stock Sale -$65.2K -282 0% $231.07 28.9M Jan 19, 2022 Direct F1, F2, F7
transaction CRM Common Stock Sale -$10.9K -47 0% $231.96 28.9M Jan 19, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2.3K -0.5% $0.00 454K Jan 19, 2022 Common Stock 2.3K $80.99 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
F2 Other than the shares subject to the transactions reported in this Form 4 (which are held in the reporting person's name), shares are held in the Marc R. Benioff Revocable Trust.
F3 Weighted average price. These shares were sold in multiple transactions at prices ranging from $226.2600 to $227.2000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 Weighted average price. These shares were sold in multiple transactions at prices ranging from $227.3700 to $228.2700 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 Weighted average price. These shares were sold in multiple transactions at prices ranging from $228.4500 to $229.4300 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 Weighted average price. These shares were sold in multiple transactions at prices ranging from $229.7100 to $230.6800 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 Weighted average price. These shares were sold in multiple transactions at prices ranging from $230.7400 to $231.5600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F8 Option vests over four years at the rate of 25% on November 22, 2016, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.